The Source Blog
Recent Action in Pharmaceuticals
HB 0052 – Utah
Introduced: 2025 Status:
This bill introduces new regulations for health insurance plans and drug discount coupons in Utah, focusing on how cost-sharing requirements are calculated and applied. The bill defines key terms like “biosimilar” (a biological product highly […]
HB 0519 – Utah
Introduced: 2025 Status:
This bill addresses the 340B drug discount program by establishing new regulations for pharmaceutical manufacturers. The 340B program allows certain healthcare providers, such as hospitals and community health centers, to purchase prescription drugs at discounted […]
HB 1041 – Virginia
Introduced: 2025 Status: In Process
This bill addresses several key provisions related to health insurance, pharmacy benefits managers (PBMs), and prescription drug cost-sharing. The bill requires that an enrollee’s out-of-pocket costs (defined cost-sharing) for prescription drugs be calculated at the […]
HB 2380 – Virginia
Introduced: 2025 Status: In Process
This bill establishes a Pharmacy Benefits Manager (PBM) and Third-Party Administrator Oversight Work Group to address prescription drug costs and healthcare expenses in Virginia. The Work Group, convened by the Secretary of Health and Human […]
HB 2831 – West Virginia
Introduced: 2025 Status: In Process
This bill creates the West Virginia Prescription Drug Affordability Board (the Board), a new state entity designed to address high prescription drug costs. The Board will consist of five members appointed by various state officials, […]
SB 62 – New Mexico
Introduced: 2025 Status: In Process
This bill amends the Pharmacy Benefits Manager (PBM) Regulation Act to introduce more stringent oversight and transparency for pharmacy benefits managers. The legislation defines key terms such as “bona fide service fee” as a flat […]
SB 503 – New Mexico
Introduced: 2025 Status: In Process
This bill amends New Mexico’s Pharmacy Benefits Manager (PBM) Regulation Act to introduce several new definitions and prohibit certain practices by pharmacy benefits managers. The bill defines new terms like “patient steering,” which includes directing […]
Next | See all Legislation Records
Introduced: 2025 Status:
This bill introduces new regulations for health insurance plans and drug discount coupons in Utah, focusing on how cost-sharing requirements are calculated and applied. The bill defines key terms like “biosimilar” (a biological product highly […]
HB 0519 – Utah
Introduced: 2025 Status:
This bill addresses the 340B drug discount program by establishing new regulations for pharmaceutical manufacturers. The 340B program allows certain healthcare providers, such as hospitals and community health centers, to purchase prescription drugs at discounted […]
HB 1041 – Virginia
Introduced: 2025 Status: In Process
This bill addresses several key provisions related to health insurance, pharmacy benefits managers (PBMs), and prescription drug cost-sharing. The bill requires that an enrollee’s out-of-pocket costs (defined cost-sharing) for prescription drugs be calculated at the […]
HB 2380 – Virginia
Introduced: 2025 Status: In Process
This bill establishes a Pharmacy Benefits Manager (PBM) and Third-Party Administrator Oversight Work Group to address prescription drug costs and healthcare expenses in Virginia. The Work Group, convened by the Secretary of Health and Human […]
HB 2831 – West Virginia
Introduced: 2025 Status: In Process
This bill creates the West Virginia Prescription Drug Affordability Board (the Board), a new state entity designed to address high prescription drug costs. The Board will consist of five members appointed by various state officials, […]
SB 62 – New Mexico
Introduced: 2025 Status: In Process
This bill amends the Pharmacy Benefits Manager (PBM) Regulation Act to introduce more stringent oversight and transparency for pharmacy benefits managers. The legislation defines key terms such as “bona fide service fee” as a flat […]
SB 503 – New Mexico
Introduced: 2025 Status: In Process
This bill amends New Mexico’s Pharmacy Benefits Manager (PBM) Regulation Act to introduce several new definitions and prohibit certain practices by pharmacy benefits managers. The bill defines new terms like “patient steering,” which includes directing […]
Next | See all Legislation Records
Merck & Co., Inc. v. Becerra, et al. – Federal
District Court: District of Columbia Status: Pending
A complaint filed by Merck, a multinational pharmaceutical company, alleges that the drug price negotiation process detailed in the Inflation Reduction Act (IRA) violates the […]
FTC v. Amgen Inc. & Horizon Therapeutics Plc. – Federal
District Court: Northern District of Illinois, Eastern Division Status: Pending
The FTC filed a lawsuit requesting a temporary restraining order and preliminary injunction to block Amgen Inc. from acquiring Horizon Therapeutics. Amgen agreed to purchase […]
PhRMA v. Stolfi – Oregon
District Court: District Court of Oregon Status: Decided
PhRMA is challenging Oregon’s drug price transparency laws HB 4005, 2018 (Disclosure Law) and HB 2658, 2019 (Advance Notification Law) alleging that the laws are […]
Pharmaceutical Care Management Association (PCMA) v. Mulready – Oklahoma
District Court: District Court of Western District of Oklahoma Status: Decided
The 2019 Oklahoma law, Patient’s Right to Pharmacy Choice Act, targets PBM conflict of interest by prohibiting higher reimbursement rates for PBM-owned pharmacies and bans […]
State of Ohio v. OptumRx – Ohio
District Court: Ohio Court of Common Pleas (Franklin County) Status: Pending
On March 15, 2019, Ohio’s attorney general Dave Yost sued OptumRx in Ohio state court, claiming that between 2015 and 2018, the PBM failed to pass […]
Pharm. Care Mgmt. Ass’n v. Gerhart – Iowa
District Court: Southern District of Iowa Status: Decided
Trade association representing pharmacy benefits managers (PBM) brought action against State of Iowa, seeking declaration that statute that regulated how PBMs established generic drug pricing […]
Pharm. Care Mgmt. Ass’n v. Tufte – North Dakota
District Court: District of North Dakota Status: Pending
Trade association representing pharmacy benefit managers (PBMs) brought action against North Dakota state officials in their official capacities, alleging that Employee Retirement Income Security Act […]
Next | See all Litigation Records
District Court: District of Columbia Status: Pending
A complaint filed by Merck, a multinational pharmaceutical company, alleges that the drug price negotiation process detailed in the Inflation Reduction Act (IRA) violates the […]
FTC v. Amgen Inc. & Horizon Therapeutics Plc. – Federal
District Court: Northern District of Illinois, Eastern Division Status: Pending
The FTC filed a lawsuit requesting a temporary restraining order and preliminary injunction to block Amgen Inc. from acquiring Horizon Therapeutics. Amgen agreed to purchase […]
PhRMA v. Stolfi – Oregon
District Court: District Court of Oregon Status: Decided
PhRMA is challenging Oregon’s drug price transparency laws HB 4005, 2018 (Disclosure Law) and HB 2658, 2019 (Advance Notification Law) alleging that the laws are […]
Pharmaceutical Care Management Association (PCMA) v. Mulready – Oklahoma
District Court: District Court of Western District of Oklahoma Status: Decided
The 2019 Oklahoma law, Patient’s Right to Pharmacy Choice Act, targets PBM conflict of interest by prohibiting higher reimbursement rates for PBM-owned pharmacies and bans […]
State of Ohio v. OptumRx – Ohio
District Court: Ohio Court of Common Pleas (Franklin County) Status: Pending
On March 15, 2019, Ohio’s attorney general Dave Yost sued OptumRx in Ohio state court, claiming that between 2015 and 2018, the PBM failed to pass […]
Pharm. Care Mgmt. Ass’n v. Gerhart – Iowa
District Court: Southern District of Iowa Status: Decided
Trade association representing pharmacy benefits managers (PBM) brought action against State of Iowa, seeking declaration that statute that regulated how PBMs established generic drug pricing […]
Pharm. Care Mgmt. Ass’n v. Tufte – North Dakota
District Court: District of North Dakota Status: Pending
Trade association representing pharmacy benefit managers (PBMs) brought action against North Dakota state officials in their official capacities, alleging that Employee Retirement Income Security Act […]
Next | See all Litigation Records
News & Opinions
Articles & Reports
New England Journal of Medicine
March 22, 2025
JAMA Network February 28, 2025
Health Affairs Forefront January 14, 2025
Value in Health Journal December 1, 2024
JAMA Network February 28, 2025
Health Affairs Forefront January 14, 2025
Value in Health Journal December 1, 2024
Trends in Pharmaceuticals
2019 Pharmaceutical Legislation
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2019 session.
-
Key:
- Enacted
- Considered
- No Legislative Session
Price Transparency
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2018 session.
-
Key:
- Enacted
- Considered
- No Legislative Session
Rate Setting
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2018 session.
-
Key:
- Enacted
- Considered
- No Legislative Session
Price Gouging
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2018 session.
-
Key:
- Enacted
- Considered
- No Legislative Session
Drug Importation
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2018 session.
-
Key:
- Enacted
- Considered
- No Legislative Session
Pharmacy Gag Clause Regulation
Gag clause regulation includes laws that allow pharmacists to disclose costs to insured patients and those that prohibit pharmacists from collecting more in cost-sharing from the insured patient than the cash price. See The Source’s Spotlight on 2018 State Drug Legislation Part 3 and 2018 legislation chart for more information.
-
Key:
- Enacted
- Considered
- No Legislative Session
PBM Regulation
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2018 session.
-
Key:
- Enacted
- Considered
- No Legislative Session
Pharma Other
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2018 session.
-
Key:
- Enacted
- Considered
- No Legislative Session